Skip to main content
Log in

Thyroid abnormalities in lithium-treated patients

  • Published:
Advances in Therapy Aims and scope Submit manuscript

Abstract

The purposes of this study were to evaluate possible effects of lithium on thyroid function, determine the relationship among thyroid function, antibody levels, and demographic/clinical variables, and establish the prevalence of lithiumrelated goiter, clinical hypothyroidism, and thyroid antibodies. Forty-nine patients who had taken lithium for a minimum of 6 months were enrolled, as were 46 age- and sex-matched controls naïve to lithium use. Blood was drawn to measure levels of total and free T3, T4, thyroid-stimulating hormone (TSH), and antimicrosomal and antithyroglobulin antibodies. Thyroid volume was quantified on ultrasonography. Twenty-nine patients in the study group (59%) and 7 in the control group (15%) had goiter. Free T4 levels were significantly lower in the study group, and TSH levels were higher. Among lithium-treated patients, 12% had clinical hypothyroidism and 2% had subclinical hypothyroidism. Thyroid antibodies were present in 23% of the lithium group and 15% of the control group. No significant relationship was apparent among thyroid antibodies, thyroid volume, and clinical hypothyroidism. Our findings suggested that along with its goitrogenic effects, lithium inhibited thyroid function and led to clinical hypothyroidism. Older age, family history of thyroid disorders, and the presence of thyroid antibodies significantly influenced thyroid function in the present study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Jacobson JL, Jacobson MA. Mood-stabilizing agents. In: Jacobson JL, ed.Psychiatric Secrets. Canada: Times Mirror Professional Publishing; 1996:277–285.

    Google Scholar 

  2. Fernandez BA. Autoimmune thyrotoxicosis during lithium therapy in a patient with manicdepressive illness.Am J Med. 1995;99:575.

    Article  Google Scholar 

  3. Honig A, Arts BMG, Ponds RHWM, Riedel WJ. Lithium induced cognitive side-effects in bipolar disorder: a qualitative analysis and implications for daily practice.Int Clin Psychopharmacol. 1999; 14:167–171.

    Article  PubMed  CAS  Google Scholar 

  4. Deodhar SD, Sing B, Pathak MC, Sharan P, Kulhara P. Thyroid functions in lithium-treated psychiatric patients.Biol Trace Element Res. 1998;67:151–163.

    Article  Google Scholar 

  5. Gekenberg JA, Hopkins SH, Delgada LP. Mood stabilizers. In: Tasman A, Kay J, Lieberman AJ, eds.Psychiatry. Philadelphia: WB Saunders; 1997:1586–1605.

    Google Scholar 

  6. Kleiner J, Altshuler L, Hendrick V, Hersman MJ. Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment.J Clin Psychiatry. 1999;60:255–294.

    Article  Google Scholar 

  7. Bhandari S. Lithium-induced hypothyroidism.Br J Psychiatry. 2000;176:95.

    Article  PubMed  CAS  Google Scholar 

  8. Johnston MA, Eagles MJ. Lithium-associated clinical hypothyroidism.Br J Psychiatry. 1999;175: 336–339.

    Article  PubMed  CAS  Google Scholar 

  9. Bocchetta A, Bernardi F, Pedditzi M, et al. Thyroid abnormalities during lithium treatment.Acta Psychiatr Scand. 1991;83:193–198.

    Article  PubMed  CAS  Google Scholar 

  10. Hassman AR, Lazarus HJ, Dieguez C, Weetman AP, Hall R, McGregor AM. The influence of lithium chloride on experimental autoimmune thyroid disease.Clin Exp Immunol. 1985;61:49–57.

    PubMed  CAS  Google Scholar 

  11. Deniker P, Eyquem A, Bernheim R, Loo H, Delarue P. Thyroid autoantibody levels during lithium therapy.Neuropsychobiology. 1978;4:270–275.

    Article  PubMed  CAS  Google Scholar 

  12. Rapaport HM, Schmit EM, Risinger R, Manji H. The effects of prolonged lithium exposure on the immune system of normal control subjects: serial serum soluble interleukin-2 receptor and antithyroid antibody measurements.Biol Psychiatry. 1994;35:761–766.

    Article  PubMed  CAS  Google Scholar 

  13. Shimizu M, Hirokawa M, Manabe T, Shimozuma K, Sonoo H, Harada T. Lithium associated autoimmune thyroiditis.J Clin Pathol. 1997;50:172–174.

    Article  PubMed  CAS  Google Scholar 

  14. Lazarus HJ, McGregor MA, Ludgate M, Darke C, Creagh MF, Kingswood JC. Effect of lithium carbonate therapy on thyroid immune status in manic depressive patients: a prospective study.J Affect Disord. 1986;11:155–160.

    Article  PubMed  CAS  Google Scholar 

  15. Lee S, Chow CC, Wing KY, Shek CC. Thyroid abnormalities during chronic lithium treatment in Hong Kong Chinese: a controlled study.J Affect Disord. 1992;26:173–178.

    Article  PubMed  CAS  Google Scholar 

  16. Leroy MC, Villeneuve A, Lajeunesse C. Lithium, thyroid function and antithyroid antibodies.Biol Psychiatry. 1988;12:483–490.

    CAS  Google Scholar 

  17. Kirov G. Thyroid disorders in lithium-treated patients.J Affect Disord. 1998;50:33–40.

    Article  PubMed  CAS  Google Scholar 

  18. Perrild H, Hegedus L, Baastrup PC, Kayser L, Kastberg S. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment.Am J Psychiatry. 1990; 147:1518–1521.

    PubMed  CAS  Google Scholar 

  19. American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.

    Google Scholar 

  20. Lee S, Chow CC, Wing YK, et al. Thyroid function and psychiatric morbidity in patients with manic disorder receiving lithium therapy.J Clin Psychopharmacol. 2000;20:204–209.

    Article  PubMed  CAS  Google Scholar 

  21. Bocchetta A, Cherchi A, Loviselli A, et al. Six-years follow-up of thyroid function during lithium treatment.Acta Psychiatr Scand. 1996;94:45–48.

    Article  PubMed  CAS  Google Scholar 

  22. Loviselli A, Bocchetta A, Mossa P, et al. Value of thyroid echography in the long-term follow-up of lithium-treated patients.Neuropsychobiology. 1997;36:37–41.

    Article  PubMed  CAS  Google Scholar 

  23. Kusalic M, Engelsmann F. Effect of lithium maintenance therapy on thyroid and parathyroid function.J Psychiatry Neurosci. 1999;24:227–233.

    PubMed  CAS  Google Scholar 

  24. Yamagishi S, Yokoyama-ohta M. A case of lithium-associated hyperthyroidism.Postgrad Med. 1999;75:188–189.

    CAS  Google Scholar 

  25. Sawin CT, Castelli WP, Hershman JM, McNamara P, Bacharach P. The aging thyroid: thyroid deficiency in the Framingham study.Arch Intern Med. 1985;145:1386–1388.

    Article  PubMed  CAS  Google Scholar 

  26. Wilson R, McKillop HJ, Crocket GT, et al. The effect of lithium therapy on parameters thought to be involved in the development of autoimmune thyroid disease.Clin Endocrinol. 1991;34: 357–361.

    CAS  Google Scholar 

  27. Valle J, Ayuso-Gutierrez JL, Abril A, Ayuso-Mateos LJ. Evaluation of thyroid function in lithiumnaive bipolar patients.Eur Psychiatry. 1999;14:341–345.

    Article  PubMed  CAS  Google Scholar 

  28. Frye AM, Kirk D, Denicoff K, et al. Association between lower serum free T4 and greater mood instability and depression in lithium-maintained bipolar patients.Am J Psychiatry. 1999;156: 1909–1914.

    PubMed  CAS  Google Scholar 

  29. Kupka RW, Hillegers MHJ, Nolen WA, Breunis N, Drexhage HA. Immunological aspects of bipolar disorder.Bipolar Disord. 2000;12:86–90.

    Google Scholar 

  30. Hagherty JJ, Silva SG, Marquardt M, et al. Prevalence of antithyroid antibody in mood disorder.Depress Anxiety. 1997;5:91–96.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozpoyraz, N., Tamam, L. & Kulan, E. Thyroid abnormalities in lithium-treated patients. Adv Therapy 19, 176–184 (2002). https://doi.org/10.1007/BF02848693

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02848693

Keywords

Navigation